Schmid Marianne, Sood Akshay, Campbell Logan, Kapoor Victor, Dalela Deepansh, Klett Dane E, Chun Felix K-H, Kibel Adam S, Sammon Jesse D, Menon Mani, Fisch Margit, Trinh Quoc-Dien
Center for Surgery and Public Health and Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, 45 Francis Street, Boston, MA 02115, USA; Department of Urology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg 20246, Germany.
Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, 2799 W. Grand Blvd, Detroit, MI 48202, USA.
Am J Surg. 2015 Aug;210(2):221-229.e6. doi: 10.1016/j.amjsurg.2014.12.045. Epub 2015 Apr 23.
To investigate the impact of smoking on perioperative outcomes in patients undergoing one of the 16 major cardiovascular, orthopedic, or oncologic surgical procedures.
We relied on the American College of Surgeons National Surgical Quality Improvement Program database (2005 to 2011). Procedure-specific multivariable logistic regression models assessed the association between smoking status (non, former, or current smokers) and risk of 30-day morbidity and mortality.
Overall, 141,802 patients were identified. A total of 12.5%, 14.6%, and 14.9% of non, former, and current smokers, respectively, experienced at least one complication (P < .001). In multivariable models, current smokers had higher odds of overall, pulmonary, wound, and septic/shock complications following most cardiovascular and oncologic surgeries compared with nonsmokers. The odds of experiencing such adverse outcomes were significantly lower in former smokers compared with current smokers, but still higher compared with nonsmokers.
The effect of smoking on perioperative outcomes is procedure dependent. Current and, even though mitigated, former smoking negatively influence outcomes following cardiovascular or oncologic procedures. Patients undergoing major procedures should be encouraged to discontinue tobacco smoking to achieve optimal procedural outcomes.
探讨吸烟对接受16种主要心血管、骨科或肿瘤外科手术之一的患者围手术期结局的影响。
我们使用了美国外科医师学会国家外科质量改进计划数据库(2005年至2011年)。特定手术的多变量逻辑回归模型评估了吸烟状态(从不吸烟、曾经吸烟或当前吸烟)与30天发病率和死亡率风险之间的关联。
总体而言,共识别出141,802例患者。从不吸烟、曾经吸烟和当前吸烟的患者中,分别有12.5%、14.6%和14.9%至少经历了一种并发症(P <.001)。在多变量模型中,与不吸烟者相比,大多数心血管和肿瘤手术后,当前吸烟者出现总体、肺部、伤口和感染/休克并发症的几率更高。曾经吸烟者出现此类不良结局的几率与当前吸烟者相比显著降低,但与不吸烟者相比仍更高。
吸烟对围手术期结局的影响因手术而异。当前吸烟以及尽管影响减轻但曾经吸烟都会对心血管或肿瘤手术后的结局产生负面影响。应鼓励接受大型手术的患者戒烟以实现最佳手术结局。